294 related articles for article (PubMed ID: 17123443)
1. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of severe bruxism with botulinum toxin type A].
Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin injection for bruxism associated with brain injury: case report.
Kesikburun S; Alaca R; Aras B; Tuğcu I; Tan AK
J Rehabil Res Dev; 2014; 51(4):661-4. PubMed ID: 25144179
[TBL] [Abstract][Full Text] [Related]
4. Bruxism after brain injury: successful treatment with botulinum toxin-A.
Ivanhoe CB; Lai JM; Francisco GE
Arch Phys Med Rehabil; 1997 Nov; 78(11):1272-3. PubMed ID: 9365360
[TBL] [Abstract][Full Text] [Related]
5. The treatment of masseter hypertrophy with botulinum toxin type A.
Al-Ahmad HT; Al-Qudah MA
Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
[TBL] [Abstract][Full Text] [Related]
6. Trismus after stroke/TBI: botulinum toxin benefit and use pre-PEG placement.
Restivo DA; Maimone D; Patti F; Marchese-Ragona R; Marino G; Pavone A
Neurology; 2005 Jun; 64(12):2152-3. PubMed ID: 15985596
[No Abstract] [Full Text] [Related]
7. The use of botulinum toxin for the treatment of temporomandibular disorder.
Freund B; Schwartz M
Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334
[No Abstract] [Full Text] [Related]
8. Treatment of a tardive dyskinesia patient with temporomandibular disorder: a case report.
Pekkan G; Kilicoglu A; Algin DI
J Orofac Pain; 2010; 24(2):212-6. PubMed ID: 20401360
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
[No Abstract] [Full Text] [Related]
10. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
[TBL] [Abstract][Full Text] [Related]
11. The medical management of masseteric hypertrophy with botulinum toxin.
Finn S; Ryan P; Sleeman D
J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
[TBL] [Abstract][Full Text] [Related]
12. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
[TBL] [Abstract][Full Text] [Related]
13. Lower facial contouring with botulinum toxin type A.
Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report.
Pidcock FS; Wise JM; Christensen JR
J Oral Maxillofac Surg; 2002 Jan; 60(1):115-7. PubMed ID: 11757023
[No Abstract] [Full Text] [Related]
15. Botulinum toxin for the treatment of congenital entropion.
Christiansen G; Mohney BG; Baratz KH; Bradley EA
Am J Ophthalmol; 2004 Jul; 138(1):153-5. PubMed ID: 15234303
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for radiation-induced facial pain and trismus.
Hartl DM; Cohen M; Juliéron M; Marandas P; Janot F; Bourhis J
Otolaryngol Head Neck Surg; 2008 Apr; 138(4):459-463. PubMed ID: 18359354
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
Ihde SK; Konstantinovic VS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A for treating muscular contractures in cephalic tetanus.
García-García A; Gándara-Rey JM; Crespo-Abelleira A; Jorge-Barreiro J
Br J Oral Maxillofac Surg; 2007 Oct; 45(7):573-5. PubMed ID: 17023100
[TBL] [Abstract][Full Text] [Related]
19. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
[TBL] [Abstract][Full Text] [Related]
20. Botulism toxin: use in disorders of the temporomandibular joint.
Chang H
Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
